Developing Advanced & Reliable Biomarkers of CNS Pathology to Generate Clinically Validated Results

Time: 9:15 am
day: Conference Day One

Details:

  • Enhancing biological understanding of imaging and fluid-based biomarkers to accelerate their utility as pharmacodynamic biomarkers.
  • Exploring the ability for fluid and imaging biomarkers to provide reliable and validated measurements of therapeutic outcome.
  • Current understanding and examples for validation of multi-modal biomarkers and promising models for developing advanced biomarkers of neuroinflammation across CNS Disorders.

Speakers: